Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarate for treating relapsing multiple sclerosis.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
miFRame: analysis and visualization of miRNA sequencing data in neurological disorders.
Desirability and expectations of the UK MS Register: Views of people with MS.
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
Distribution of CD4(pos) -, CD8(pos) - and Regulatory T Cells in the Upper and Lower Gastrointestinal Tract in Healthy Young Subjects.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
The Increasing Prevalence of Multiple Sclerosis in New Zealand.
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.
Sex Chromosome Complement Influences Functional Callosal Myelination.
Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis.
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
Myelinating cocultures of rat retinal ganglion cell reaggregates and optic nerve oligodendrocyte precursor cells.
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.
[Clinical outcome of the hyperacute form of acute disseminated encephalomyelitis.]
Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
Chronic cerebrospinal venous insufficiency in multiple sclerosis: A sonographer-blinded case-control study.
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
Optic neuritis revealing Kikuchi-Fujimoto's disease: clinical commentary.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
Pages
« first
‹ previous
…
596
597
598
599
600
601
602
603
604
…
next ›
last »